NovoCure (NVCR) Payables (2014 - 2026)
NovoCure (NVCR) posted Payables of $130.7 million for Q2 2026, up 2.74% sequentially from $127.2 million in Q1 2026, and down 80.3% YoY from $663.5 million in Q2 2025.
NovoCure (NVCR) Payables (2014 - 2026) Analysis & Trends
NovoCure has reported Payables for 13 years, with the latest figure at $130.7 million in Q2 2026.
- Quarterly Payables fell 80.3% year-over-year to $130.7 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $130.7 million (down 80.3% YoY) and the FY2025 annual result came in at $122.2 million, down 81.57% from the prior year.
- Payables rose to $130.7 million in Q2 2026 per NVCR's latest filing, from $127.2 million in the prior quarter.
- Over five years, Payables peaked at $679.5 million in Q3 2025 and troughed at $69.2 million in Q1 2022.
- A 5-year average of $250.7 million and a median of $92.3 million in 2023 frame the typical range for Payables.
- The sharpest annual moves came in 2024 and 2025: Payables jumped 714.19% in 2024, then tumbled 81.57% in 2025.
- Over 5 years, Payables stood at $85.2 million in 2022, then increased by 10.79% to $94.4 million in 2023, then jumped by 602.66% to $663.2 million in 2024, then sank by 81.57% to $122.2 million in 2025, then increased by 6.95% to $130.7 million in 2026.
- According to Business Quant data, Payables over the past three periods registered $130.7 million, $127.2 million, and $122.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.82 Bn | 196.22 Bn | 7.27 Bn | 5.89 Bn |
| 2 | Stryker | 126.80 Bn | 123.33 Bn | 4.50 Bn | 2.00 Bn |
| 3 | Medtronic | 118.88 Bn | 109.66 Bn | 6.41 Bn | 2.64 Bn |
| 4 | Boston Scientific | 74.25 Bn | 73.71 Bn | 3.85 Bn | 1.23 Bn |
| 5 | Edwards Lifesciences | 51.59 Bn | 47.34 Bn | 1.35 Bn | 210.50 Mn |
| 6 | Dexcom | 34.99 Bn | 33.04 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.78 Bn | 31.67 Bn | 2.18 Bn | 3.23 Bn |
| 8 | Koninklijke Philips | 26.23 Bn | 22.91 Bn | 4.55 Bn | 2.51 Bn |
| 9 | Steris | 23.16 Bn | 22.68 Bn | 684.20 Mn | 587.50 Mn |
| 10 | NovoCure | 1.99 Bn | 1.55 Bn | 142.48 Mn | 130.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 130.73 Mn |
| Mar 31, 2026 | 127.24 Mn |
| Dec 31, 2025 | 122.23 Mn |
| Sep 30, 2025 | 679.54 Mn |
| Jun 30, 2025 | 663.47 Mn |
| Mar 31, 2025 | 654.06 Mn |
| Dec 31, 2024 | 663.25 Mn |
| Sep 30, 2024 | 648.65 Mn |
| Jun 30, 2024 | 90.17 Mn |
| Mar 31, 2024 | 84.32 Mn |
| Dec 31, 2023 | 94.39 Mn |
| Sep 30, 2023 | 79.67 Mn |
| Jun 30, 2023 | 82.54 Mn |
| Mar 31, 2023 | 81.47 Mn |
| Dec 31, 2022 | 85.20 Mn |
| Sep 30, 2022 | 77.03 Mn |
| Jun 30, 2022 | 79.91 Mn |
| Mar 31, 2022 | 69.19 Mn |
| Dec 31, 2021 | 72.60 Mn |
| Sep 30, 2021 | 60.01 Mn |